Telomere Aggregates in Hepatitis C Patients

REFERENCES

• Kim N. W., Piatyszek M. A., Prowse K. R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–2015
   PubMed Web of Science ®Google Scholar
• Shay J. W., Bacchetti S. A. A survey to telomerase activity in human cancer. Eur J Cancer 1997; 33: 787–791
   PubMed Web of Science ®Google Scholar
• Counter C. M., Avilion A. A., LeFeuvre C. E., et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11: 1921–1929
   PubMed Web of Science ®Google Scholar
• Greider C. W. Mammalian telomere dynamics: healing, fragmentation shortening, and stabilization. Curr Opin Genet Dev 1994; 4: 203–211
   PubMedGoogle Scholar
• de Lange T., Shiue L., Myers R. M., et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990; 10: 518–527
   PubMed Web of Science ®Google Scholar
• Dynek J. N., Smith S. Resolution of sister telomere association is required for progression through mitosis. Science 2004; 304: 97–100
   PubMed Web of Science ®Google Scholar
• Pathak S., Multani A. S. Aneuploidy, stem cells and cancer. Cancer Cell Struct Carcinog Genom Instab 2006; 96: 49–64
   Google Scholar
• Chuang T. C.Y., Moshir S., Garini Y., et al. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2004; 2: 12
   PubMed Web of Science ®Google Scholar
• Louis S. F., Vermoten B. J., Garini Y., et al. C-myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 2005; 102: 9613–9618
   PubMed Web of Science ®Google Scholar
• DePinho R. A., Polyak K. Cancer chromosomes in crisis. Nat Genet 2004; 36: 932–934
   Google Scholar
• Artandi S. E., Chung S., Lee S. L., et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406: 641–644
   PubMed Web of Science ®Google Scholar
• Murnane J. P., Sabatier L. Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bio Essays 2004; 26: 1164–1174
   PubMed Web of Science ®Google Scholar
• Muller H. J. The remaking of chromosomes. Collect Net 1938; 13: 181–198
   Google Scholar
• McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941; 26: 234–282
   PubMedGoogle Scholar
• McClintock B. The fusion of broken ends of chromosomes following nuclear fusion. Proc Natl Acad Sci USA 1942; 28: 458–463
   PubMedGoogle Scholar
• Mai S., Garini Y. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 2006; 97: 904–915
   PubMed Web of Science ®Google Scholar
• Goldberg-Bittman L., Kitay-Cohen Y., Quitt M., Hadary R., Fejgin M. D., Yukla M., Amiel A. Telomere aggregates in non-Hodgkin's lymphoma (NHL) patients at different disease stages. Cancer Genet Cytogenet. 2008, in press
   Google Scholar
• Monteverde A., Rivano M. T., Allegra G. C., et al. Essential mixed cryoglobulinemia type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acata Haematol 1988; 79: 20–25
   PubMed Web of Science ®Google Scholar
• Coleman W. B. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003; 3: 573–588
   PubMed Web of Science ®Google Scholar
• Sekoguchi S., Nakajima T., Moriguchi M., et al. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis. C.J. Gastoenterol Hepatol 2007; 22: 182–190
   PubMed Web of Science ®Google Scholar
• Goldberg-Bittman L., Kitay-Cohen Y., Hadari R., et al. Random aneuploidy in chronic hepatitis C patients and in remission. Cancer Genet Cytogenet 2008; 180: 20–23
   PubMed Web of Science ®Google Scholar
• Smirnova I., Aksenov N. D., Kashuba E. V., et al. Hepatitis C virus core protein transforms murine fibroblasts by promoting genomic instability. Cell Oncol 2006; 28: 177–190
   PubMedGoogle Scholar
• Mise K., Tashiro S., Yogita S., et al. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res 1998; 4: 1475–1482
   PubMed Web of Science ®Google Scholar
• Kato A., Kubo K., Kurokawa F., et al. Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma: a FISH and FCM analysis of 20 cases. Dig Dis Sci 1998; 43: 1–7
   PubMed Web of Science ®Google Scholar
• Terris B., Ingster O., Rubbia L., et al. Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J Hepatol 1997; 27: 313–319
   PubMed Web of Science ®Google Scholar
• Amiel A., Goldzak G., Gaber E., et al. Random aneuploidy and telomere capture in chronic lymphocytic leukemia and chronic myeloid leukemia patients. Cancer Genet Cytogenet 2005; 163: 12–16
   PubMed Web of Science ®Google Scholar
• Amiel A., Gronich N., Yukla M., et al. Random aneuploidy in neoplastic and preneoplastic diseases, multiple myeloma, and monoclonal gammopathy. Cancer Genet Cytogenet 2005; 162: 78–81
   PubMed Web of Science ®Google Scholar
• Amiel A., Yukla M., Gaber E., et al. Random aneuploidy in CML patients at diagnosis and under imatinib treatment. Cancer Genet Cytogenet 2006; 168: 120–123
   PubMed Web of Science ®Google Scholar
• Amiel A., Elis A., Blumenthal D., et al. Modified order of allelic replication in lymphoma patients at different disease stages. Cancer Genet Cytogenet 2001; 125: 156–160
   PubMed Web of Science ®Google Scholar
• Amiel A., Kitay-Cohen Y., Fejgin M. D., et al. Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol 2000; 28: 156–160
   PubMed Web of Science ®Google Scholar
• Tokita H., Fukui H., Tanaka A., et al. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroentero Hepato 2005; 20: 752–758
   PubMed Web of Science ®Google Scholar
• Chavalitdhamrong D., Tanwandee T. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment. World J Gastroenterol 2006; 12: 5532–5535
   PubMed Web of Science ®Google Scholar
• Tanaka A., Uegaki S., Kurihara H., et al. Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C. World J Gastroenterol 2007; 13: 5180–5187
   PubMed Web of Science ®Google Scholar